Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Scientists at Quris Technologies have uncovered evidence that some drugs become significantly more harmful to brain ...

Targeting an enzyme can help stop the growth of glioblastoma, the most dangerous type of brain tumour, researchers have found ...

A research team has developed a technology to boost cancer treatment effectiveness by removing a protein used by cancer cells ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

These infections—systemic, lethal infestations of the body’s deep tissues and organs—have little in common with the ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

A team of researchers from the Institute for Basic Science (IBS) in South Korea has made an important discovery that could ...

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...

The author team introduces the terms 'exozymes' to bring clarity to the rapidly evolving field of cell-free ...